Purchase Order 75N93018P00710
Award Date 5/15/18
Potential Completion Date 5/31/19
Potential Value $24K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Burien, WA 98168, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a $24,605 firm fixed-price purchase order to Stemcell Technologies Inc., a foreign-owned for-profit organization, for the delivery of Human Cell Enrichment Kits. This contract did not have a set-aside designation. Stemcell Technologies Inc. is a subsidiary of the Canadian company Stemcell Technologies, which develops specialized biological materials,...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $15,645.00 Firm Fixed Price Purchase Order to Stemcell Technologies Inc., a foreign-owned for-profit organization, for the provision of HUMAN CD8 KITS. This award was not set aside for any specific business category. Stemcell Technologies Inc. is a subsidiary of the Canadian company Stemcell Technologies, which develops cell culture media, cell separation...
- The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a $17,450.00 Firm Fixed Price purchase order contract to Stemcell Technologies Inc., a Canadian-owned for-profit organization, for the delivery of HUMAN CD8 KITS. The contract has a completion date of June 22, 2018 and does not have a set-aside designation. Stemcell Technologies Inc. is an active supplier of specialized biological materials, laboratory...
- This is a firm fixed-price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center to Stemcell Technologies Inc., a foreign-owned, for-profit biotechnology company headquartered in Canada. The $84,089.26 contract is for the provision of specialized biological materials, laboratory supplies, and scientific equipment to support biomedical research across various NIH institutes and centers, including the National Institute of Allergy and Infectious Diseases,...
- This is a $24,970.00 firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services (HHS), to Stemcell Technologies Inc., a Canadian biotechnology company. The contract, which has no set-aside designation, is for the delivery of various cell culture research products, such as cell isolation kits, cell culture media, and automated cell separation instruments, to support biomedical...
- The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services (HHS), awarded a $45,760.35 firm-fixed-price purchase order contract to Stemcell Technologies Inc. on January 31, 2017. The contract is for an "Immunomagnetic Cell Separator" and had a completion date of February 28, 2017. Stemcell Technologies Inc. is a Canadian biotechnology company that specializes in cell culture media, cell separation systems, and...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $100,836.00 firm-fixed-price purchase order contract to Stemcell Technologies Inc., a Canadian-owned for-profit company, to provide EASYSEP ENRICHMENT KITS. This contract has a performance period from July 5, 2017 to July 5, 2018 and was not set aside for a particular type of small business. Stemcell Technologies Inc. is an established federal contractor...
- Stemcell Technologies Inc., a Canadian biotechnology company, was awarded a $7,485 firm-fixed-price purchase order contract (HHSN272201100756P) by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services. The contract, which does not have a small business set-aside, was awarded on August 10, 2011 with a completion date of July 30, 2012. Stemcell Technologies Inc. primarily...
- This is a $6,493.50 firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Stemcell Technologies Inc., a Canadian biotechnology company specializing in cell culture media, cell separation systems, and other life sciences research products. The contract is not set aside for small businesses. Stemcell Technologies Inc. primarily acts as a prime contractor, providing a range of biological materials, laboratory supplies, and specialized...
- This is a firm fixed-price purchase order awarded to Stemcell Technologies Inc., a foreign-owned, for-profit biotechnology company, by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) under the U.S. Department of Health and Human Services. The contract is for the delivery of specialized cell culture kits, including the STEMDIFF MICROGLIA DIFFERENTIATION KIT, STEMDIFF MICROGLIA MATURATION KIT, and STEMDIFF HEMATOPOETIC...